233 related articles for article (PubMed ID: 34884649)
21. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
22. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
[TBL] [Abstract][Full Text] [Related]
23. ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells.
Drake JM; Strohbehn G; Bair TB; Moreland JG; Henry MD
Mol Biol Cell; 2009 Apr; 20(8):2207-17. PubMed ID: 19225155
[TBL] [Abstract][Full Text] [Related]
24. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
25. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
26. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.
Larsen JE; Nathan V; Osborne JK; Farrow RK; Deb D; Sullivan JP; Dospoy PD; Augustyn A; Hight SK; Sato M; Girard L; Behrens C; Wistuba II; Gazdar AF; Hayward NK; Minna JD
J Clin Invest; 2016 Sep; 126(9):3219-35. PubMed ID: 27500490
[TBL] [Abstract][Full Text] [Related]
27. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
Hou L; Li Q; Yu Y; Li M; Zhang D
Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
[TBL] [Abstract][Full Text] [Related]
28. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
29. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
Putzke AP; Ventura AP; Bailey AM; Akture C; Opoku-Ansah J; Celiktaş M; Hwang MS; Darling DS; Coleman IM; Nelson PS; Nguyen HM; Corey E; Tewari M; Morrissey C; Vessella RL; Knudsen BS
Am J Pathol; 2011 Jul; 179(1):400-10. PubMed ID: 21703419
[TBL] [Abstract][Full Text] [Related]
30. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
[TBL] [Abstract][Full Text] [Related]
31. The Transcription Factors Zeb1 and Snail Induce Cell Malignancy and Cancer Stem Cell Phenotype in Prostate Cells, Increasing Androgen Synthesis Capacity and Therapy Resistance.
López-Moncada F; Castellón EA; Contreras HR
Adv Exp Med Biol; 2022; 1393():51-64. PubMed ID: 36587301
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.
Fang C; Zan J; Yue B; Liu C; He C; Yan D
J Gastroenterol Hepatol; 2017 Jun; 32(6):1204-1211. PubMed ID: 27862275
[TBL] [Abstract][Full Text] [Related]
33. USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics.
Liu YJ; Zeng SH; Zhang W; Li JP; Yin Y; Zhuang YW; Zhou JY; Liu SL; Zou X
Pharmacol Res; 2023 Feb; 188():106644. PubMed ID: 36603607
[TBL] [Abstract][Full Text] [Related]
34. TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.
Leshem O; Madar S; Kogan-Sakin I; Kamer I; Goldstein I; Brosh R; Cohen Y; Jacob-Hirsch J; Ehrlich M; Ben-Sasson S; Goldfinger N; Loewenthal R; Gazit E; Rotter V; Berger R
PLoS One; 2011; 6(7):e21650. PubMed ID: 21747944
[TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.
Siddiqui A; Vazakidou ME; Schwab A; Napoli F; Fernandez-Molina C; Rapa I; Stemmler MP; Volante M; Brabletz T; Ceppi P
J Pathol; 2017 Jun; 242(2):221-233. PubMed ID: 28337746
[TBL] [Abstract][Full Text] [Related]
36. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
Jägle S; Dertmann A; Schrempp M; Hecht A
Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
[TBL] [Abstract][Full Text] [Related]
37. Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out.
Merckens A; Sieler M; Keil S; Dittmar T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139138
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.
Jiang R; Zhang C; Liu G; Gu R; Wu H
J Cell Biochem; 2017 Nov; 118(11):3765-3774. PubMed ID: 28379605
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
40. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks.
Soleymani L; Zarrabi A; Hashemi F; Hashemi F; Zabolian A; Banihashemi SM; Moghadam SS; Hushmandi K; Samarghandian S; Ashrafizadeh M; Khan H
Curr Cancer Drug Targets; 2021; 21(9):749-767. PubMed ID: 34077345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
